Cost-Effectiveness Analysis of Atezolizumab Compared To The Standard of Care For The Treatment of Adult Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) After Prior Chemotherapy in Greece
Abstract
Authors
N Kourkoulas D Kyriopoulos K Athanasakis